OliX Pharmaceuticals, Inc. · 올릭스 주식회사
Last · KOSDAQ₩13320.00-94980.00 (-87.70%)stale · yahoo · 19616h ago
Market cap——
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
₩84000.00₩217000.00
Volume—session
| Revenue | ₩11.0B |
|---|---|
| Operating income | ₩-39.0B |
| Net income | ₩-17.5B |
| Operating margin | -353.3% |
| Net margin | -158.7% |
| Return on equity | -7.4% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-03-18
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -107.3%
- Cash Runway Low — Cash runway ~0.4 years
- Accumulated Deficit High — Accumulated deficit / equity 128%
Documents
FormReporting forFiledFlags